Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iberfar is a prominent Portuguese pharmaceutical company founded in 1924, specializing in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company operates a state-of-the-art manufacturing facility through its subsidiary Farmalabor, providing CDMO services for solid, liquid, and semi-solid dosage forms. Iberfar maintains a strong commercial presence in the Portuguese market across multiple therapeutic areas, including cardiovascular, central nervous system, and respiratory health. In addition to its own product portfolio, the company offers integrated logistics and distribution services through Logifar, positioning itself as a comprehensive partner in the healthcare value chain. Its long-standing history and commitment to quality standards like GMP have made it a key player in the Iberian pharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iberfar.